EU says Novavax COVID vaccine should carry heart side-effect warning | Reuters
The European Medicines Agency (EMA) is recommending Novavax's COVID-19 vaccine carry a warning of two types of heart inflammation, based on a small number of reported cases, an added burden for a shot that has failed to win wide uptake.